Literature DB >> 18453372

Health-related quality of life in emphysema.

Robert M Kaplan1, Andrew L Ries.   

Abstract

Patients with emphysema may experience reduced health-related quality of life (HRQOL). HRQOL measures have evolved from two different measurement traditions: psychometric theory and decision theory. Psychometric methods typically create a profile of outcomes, whereas decision theory methods offer a summary score on a continuum ranging from 0.0 (for death or worst possible health) to 1.0 (for best possible health). Decision theory methods are better suited for cost-effectiveness studies. Generic HRQOL measures can be applied to any disease population, whereas disease-targeted measures are tailored to a specific clinical condition. Disease-targeted measures are typically more sensitive to clinical change, but cannot offer a comparison basis for different clinical conditions. This article reviews the measurement of HRQOL in patients with emphysema. The National Emphysema Treatment Trial (NETT) offers an example of the application of both generic and disease-targeted, as well as profile and decision theory, methods. The NETT illustrates how HRQOL measures can be used to assess outcomes and estimate cost-effectiveness in a major clinical trial.

Entities:  

Mesh:

Year:  2008        PMID: 18453372      PMCID: PMC2645336          DOI: 10.1513/pats.200706-080ET

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  52 in total

Review 1.  Multi-attribute health status classification systems. Health Utilities Index.

Authors:  D Feeny; W Furlong; M Boyle; G W Torrance
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 2.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

Review 3.  Quality of life assessment for cost/utility studies in cancer.

Authors:  R M Kaplan
Journal:  Cancer Treat Rev       Date:  1993       Impact factor: 12.111

4.  The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

Authors:  D G Fryback; E J Dasbach; R Klein; B E Klein; N Dorn; K Peterson; P A Martin
Journal:  Med Decis Making       Date:  1993 Apr-Jun       Impact factor: 2.583

5.  Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.

Authors:  C Bombardier; J Ware; I J Russell; M Larson; A Chalmers; J L Read
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

Review 6.  Measurement of dyspnoea in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

7.  Value judgment in the Oregon Medicaid experiment.

Authors:  R M Kaplan
Journal:  Med Care       Date:  1994-10       Impact factor: 2.983

8.  Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R M Kaplan; J P Anderson; T L Patterson; J A McCutchan; J D Weinrich; R K Heaton; J H Atkinson; L Thal; J Chandler; I Grant
Journal:  Psychosom Med       Date:  1995 Mar-Apr       Impact factor: 4.312

9.  The Ziggy theorem: toward an outcomes-focused health psychology.

Authors:  R M Kaplan
Journal:  Health Psychol       Date:  1994-11       Impact factor: 4.267

10.  Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.

Authors:  G H Guyatt; M Townsend; S O Pugsley; J L Keller; H D Short; D W Taylor; M T Newhouse
Journal:  Am Rev Respir Dis       Date:  1987-05
View more
  6 in total

Review 1.  Quality of life instruments and definitions in individuals with spinal cord injury: a systematic review.

Authors:  M R Hill; V K Noonan; B M Sakakibara; W C Miller
Journal:  Spinal Cord       Date:  2009-12-22       Impact factor: 2.772

2.  Obstructive sleep apnea in patients with end-stage lung disease.

Authors:  Ayal Romem; Aldo Iacono; Elizabeth McIlmoyle; Kalpesh P Patel; Robert M Reed; Avelino C Verceles; Steven M Scharf
Journal:  J Clin Sleep Med       Date:  2013-07-15       Impact factor: 4.062

Review 3.  Cognitive and psychological issues in emphysema.

Authors:  Elizabeth Kozora; Charles Emery; Robert M Kaplan; Fredrick S Wamboldt; Lening Zhang; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Distance saturation product predicts health-related quality of life among sarcoidosis patients.

Authors:  Julie M Bourbonnais; Subramanian Malaisamy; Bhavinkumar D Dalal; Priyan C Samarakoon; Swapna R Parikh; Lobelia Samavati
Journal:  Health Qual Life Outcomes       Date:  2012-06-13       Impact factor: 3.186

5.  Health psychology: where are we and where do we go from here?

Authors:  Robert M Kaplan
Journal:  Mens Sana Monogr       Date:  2009-01

6.  Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.

Authors:  Gerard J Criner; Antoine Delage; Kirk Voelker; D Kyle Hogarth; Adnan Majid; Michael Zgoda; Donald R Lazarus; Roberto Casal; Sadia B Benzaquen; Robert C Holladay; Adam Wellikoff; Karel Calero; Mark J Rumbak; Paul R Branca; Muhanned Abu-Hijleh; Jorge M Mallea; Ravi Kalhan; Ashutosh Sachdeva; C Matthew Kinsey; Carla R Lamb; Michael F Reed; Wissam B Abouzgheib; Phillip V Kaplan; Gregory X Marrujo; David W Johnstone; Mario G Gasparri; Arturo A Meade; Christopher A Hergott; Chakravarthy Reddy; Richard A Mularski; Amy Hajari Case; Samir S Makani; Ray W Shepherd; Benson Chen; Gregory E Holt; Simon Martel
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.